In order to investigate possible differences in amount and activity of hematopoietic stem cells of controls and ALS patients, serum concentrations of CD34+hematopoietic stem cells and IL-7 as a stem cell proliferation/differentiation promoting factor were determined. The gene discussed is CD34; the disease is amyotrophic lateral sclerosis.